Onyx Pharmaceuticals

Dr. Juergen Lasowski has been appointed senior vice president of corporate development, Onyx Pharmaceuticals. In this role, Dr. Lasowski will lead business development activities for the company, assessing opportunities to potentially expand and diversify the company’s portfolio.
   
“Juergen has a proven track record of success in corporate development and, under his leadership, we will remain poised on the business development front in order to move forward opportunistically,” said Tony Coles, M.D., president and chief executive officer of Onyx. “While Nexavar remains the core asset for Onyx and the engine for growth for our business, over time we expect to expand our portfolio as the means to build a sustainable profitable company.”
   
Most recently, Dr. Lasowski was the senior vice president of corporate development at NPS Pharmaceuticals. Previously, Dr. Lasowski held several positions at Sanofi-Aventis, in both business development and corporate strategy positions. Dr. Lasowski has completed more than 25 different business transactions and worked on three continents including North America, Europe and Asia.